Applying precision technology to improve the detection of residual disease in cancer patients
September 22, 2022
No Comments
Though early cancer diagnosis provides better outcomes for patients, many experience later disease recurrence following surgery to remove the primary tumor. This is due to
Webinar: Clinicians’ Perspectives on Circulating Tumor DNA MRD Testing in Personalizing Adjuvant Therapy for Stage II Colon Cancer
August 17, 2022
No Comments
Our webinar featured on Precision Oncology News on September 22, 2022 is now available on demand. The minimal residual disease, or MRD, testing landscape shows
